Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors.

Gliomas are the most common primary brain tumors. Hybrid PET/MR imaging has revolutionized brain tumor imaging, allowing for noninvasive, simultaneous assessment of morphologic, functional, metabolic, and molecular parameters within the brain. Molecular information obtained from PET imaging may aid in the detection, classification, prognostication, and therapeutic decision making for gliomas. ¹⁸ F-fluorodeoxyglucose (FDG) has been widely used in the setting of brain tumor imaging, and multiple techniques may be employed to optimize this methodology. More recently, a number of non- ¹⁸ F-FDG-PET radiotracers have been applied toward brain tumor imaging and are used in clinical practice.
(Copyright © 2022 Elsevier Inc. All rights reserved.)